MIF mediation of sepsis

被引：21

作者：

Martin, TR ^{[1
]}

机构：

[1] Univ Washington, Seattle VA Med Ctr, Dept Med, Seattle, WA 98108 USA

来源：

NATURE MEDICINE | 2000年 / 6卷 / 02期

关键词：

D O I：

10.1038/72230

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The individual searches for a natural antagonist of cortisol and for critical mediators of sepsis have converged in the finding that MIF is an important mediator of septic shock. The intersection of these two efforts reminds us that progress in scientific research often comes from surprising directions (164–170).

引用

页码：140 / 141

页数：2

共 12 条

[1] Why immunomodulatory therapies have not worked in sepsis [J].

Abraham, E .

INTENSIVE CARE MEDICINE, 1999, 25 (06) :556-566

[2] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].

BERNARD, GR ;

ARTIGAS, A ;

BRIGHAM, KL ;

CARLET, J ;

FALKE, K ;

HUDSON, L ;

LAMY, M ;

LEGALL, JR ;

MORRIS, A ;

SPRAGG, R ;

COCHIN, B ;

LANKEN, PN ;

LEEPER, KV ;

MARINI, J ;

MURRAY, JF ;

OPPENHEIMER, L ;

PESENTI, A ;

REID, L ;

RINALDO, J ;

VILLAR, J ;

VANASBECK, BS ;

DHAINAUT, JF ;

MANCEBO, J ;

MATTHAY, M ;

MEYRICK, B ;

PAYEN, D ;

PERRET, C ;

FOWLER, AA ;

SCHALLER, MD ;

HUDSON, LD ;

HYERS, T ;

KNAUS, W ;

MATTHAY, R ;

PINSKY, M ;

BONE, RC ;

BOSKEN, C ;

JOHANSON, WG ;

LEWANDOWSKI, K ;

REPINE, J ;

RODRIGUEZROISIN, R ;

ROUSSOS, C ;

ANTONELLI, MA ;

BELOUCIF, S ;

BIHARI, D ;

BURCHARDI, H ;

LEMAIRE, F ;

MONTRAVERS, P ;

PETTY, TL ;

ROBOTHAM, J ;

ZAPOL, W .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824

[3] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].

BERNHAGEN, J ;

CALANDRA, T ;

MITCHELL, RA ;

MARTIN, SB ;

TRACEY, KJ ;

VOELTER, W ;

MANOGUE, KR ;

CERAMI, A ;

BUCALA, R .

NATURE, 1993, 365 (6448) :756-759

[4] MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].

BLOOM, BR ;

BENNETT, B .

SCIENCE, 1966, 153 (3731) :80-&

[5] Protection from septic shock by neutralization of macrophage migration inhibitory factor [J].

Calandra, T ;

Echtenacher, B ;

Le Roy, D ;

Pugin, J ;

Metz, CN ;

Hültner, L ;

Heumann, D ;

Männel, D ;

Bucala, R ;

Glauser, MP .

NATURE MEDICINE, 2000, 6 (02) :164-170

[6] MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].

CALANDRA, T ;

BERNHAGEN, J ;

METZ, CN ;

SPIEGEL, LA ;

BACHER, M ;

DONNELLY, T ;

CERAMI, A ;

BUCALA, R .

NATURE, 1995, 377 (6544) :68-71

[7] DELAYED HYPERSENSITIVITY IN VITRO - ITS MEDIATION BY CELL-FREE SUBSTANCES FORMED BY LYMPHOID CELL-ANTIGEN INTERACTION [J].

DAVID, JR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 56 (01) :72-&

[8] Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome [J].

Donnelly, SC ;

Haslett, C ;

Reid, PT ;

Grant, IS ;

Wallace, WAH ;

Metz, CN ;

Bruce, LJ ;

Bucala, R .

NATURE MEDICINE, 1997, 3 (03) :320-323

[9] ADULT RESPIRATORY-DISTRESS SYNDROME - RISK WITH COMMON PREDISPOSITIONS [J].

FOWLER, AA ;

HAMMAN, RF ;

GOOD, JT ;

BENSON, KN ;

BAIRD, M ;

EBERLE, DJ ;

PETTY, TL ;

HYERS, TM .

ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) :593-597

[10] CLINICAL RISKS FOR DEVELOPMENT OF THE ACUTE RESPIRATORY-DISTRESS SYNDROME [J].

HUDSON, LD ;

MILBERG, JA ;

ANARDI, D ;

MAUNDER, RJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (02) :293-301

← 1 2 →